Novartis pays big fine for bribing doctors in the US
The Novartis offices in Basel, Switzerland.
Keystone / Georgios Kefalas
Swiss pharma company Novartis will pay $729 million (CHF688 million) to US authorities in an out-of-court settlement over various charges, including that the company bribed doctors to use its drugs.
This content was published on
2 minutes
Keystone-SDA/dos
Audrey Strauss, the acting Manhattan US Attorney, said the firm had paid out for “speaking fees, exorbitant meals, and top-shelf alcohol that were nothing more than bribes to get doctors across the country to prescribe Novartis’s drugs.”
Essentially, Novartis admitted to having organised thousands of lavish conferences and events ostensibly aimed at “further education”. Guest speakers were paid large amounts to attend.
In return, the doctors were incentivised to prescribe Novartis products, such as drugs for high blood pressure and diabetes, which were then reimbursed by state health authorities.
“Not only did Novartis incentivise doctors to host these speaking events, reps bribed the doctors to write more prescriptions of the company’s drugs to give Novartis an advantage over competitors within their field,” said William F Sweeney Jr, head of New York’s FBI office.
“Greed replaced the responsibility the public expects from those who practice medicine.”
As part of the agreement with US authorities, Novartis has signed a five-year code of good conduct. The Basel-based firm also said on Thursday that it was revising its methods of providing medical training, notably by planning more online webinars.
In a statement, Novartis CEO Vas Narasimhan said that the company had already changed (the charges in question were raised by a whistle-blower in 2011) and that it had “new leadership, a stronger culture, and a more comprehensive commitment to ethics”.
“With these agreements we mark an important milestone on our journey to build trust with society as we continue re-imagining medicine to improve and extend lives all around the world,” Narasimhan said.
A week ago Novartis and two of its subsidiaries admitted to further bribery schemes involving dealings in Vietnam and Greece, and agreed to pay some $347 million to settle US investigations.
As of Thursday, the stock market has not reacted particularly strongly: the Novartis share price dropped 0.8%, around the same as its competitor Roche.
Popular Stories
More
Demographics
Flat-hunting in Switzerland’s cheapest and most expensive municipalities
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Switzerland presents special toilet for cows to cut emissions
This content was published on
A toilet specially designed for cows, aimed at reducing ammonia emissions per animal by 15%, was presented at a farm in Hellbühl, canton Lucerne, on Wednesday.
Swiss petition against US F-35 fighter jets gathers 42,000 signatures
This content was published on
A petition by the "Stop-F35 Alliance" urging the Swiss government to immediately halt the purchase of new US fighter jets has gathered 42,500 signatures.
Swiss House of Representatives backs online Schengen visa system
This content was published on
In future, Schengen visa applications should be made via a European Union online platform. On Tuesday, Switzerland's House of Representatives adopted a revision of Swiss legislation on this issue.
UBS study: Switzerland is still the richest country in the world
This content was published on
Average per-capita wealth in Switzerland rose last year to $687,000 (CHF561,000), the UBS Global Wealth Report said on Wednesday.
UBS and Pictet report data leak after cyber attack on provider Chain IQ
This content was published on
Swiss banks UBS and Pictet on Wednesday confirmed they had suffered a data leak due to a cyber attack on their subcontractor Chain IQ in Switzerland.
Iran will respond firmly if US gets directly involved in Israeli strikes, says UN ambassador
This content was published on
Iran says it will respond firmly to the United States if it becomes directly involved in Israel's military campaign, the Iranian ambassador to the United Nations in Geneva said on Wednesday.
Swiss politicians concerned by cut to Lausanne-Paris TGV services
This content was published on
The Vaud cantonal parliament wants to maintain six direct daily TGV high-speed train services between Lausanne and Paris.
This content was published on
Switzerland and Norway have signed a bilateral agreement for the future storage of carbon dioxide (CO2) under the North Sea.
Switzerland must better protect whistleblowers, says OECD
This content was published on
Switzerland must step up its anti-corruption efforts and provide better protection for whistleblowers while increasing fines for guilty firms, an OECD anti-bribery group says.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Novartis CEO warns that data on Covid-19 drugs is missing
This content was published on
Potential pharmaceutical solutions to combat Covid-19 must have strong clinical data to back their efficacy, according to Novartis boss Vasant Narasimhan.
US Senate asks Novartis to shed light on data manipulation allegations
This content was published on
The Swiss pharmaceutical firm Novartis has been asked to provide details regarding possible data inaccuracies for its human gene therapy Zolgensma.
Swiss pharma giants swallow up start-ups in push for next big gene therapy
This content was published on
Swiss drug makers are increasingly relying on buying science rather than doing it themselves in the search for the next big medical breakthrough.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.